Custodio-Sánchez Piero, Damas-De Los Santos Félix, Peña-Duque Marco A, Coutiño-Castelán Daniel, Arias-Sánchez Eduardo, Abundes-Velasco Arturo, Castro-Alvarado Oscar, Colon-Arias Franklyn A, Alvarenga-Fajardo Carlos, Hernández-Fonseca César, Rodríguez-Barriga Erika, Hernández-Padilla Adolfo
Departamento de Cardiología Intervencionista, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México.
Departamento de Cardiología Intervencionista, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México.
Arch Cardiol Mex. 2018 Dec;88(5):432-440. doi: 10.1016/j.acmx.2018.03.002. Epub 2018 Apr 26.
Reclassification of a large thrombus burden is an independent predictor of major adverse cardiac events and no-reflow in patients with ST- segment elevation myocardial infarction (STEMI). Patients with a greater residual thrombus burden have worse microvascular dysfunction and greater myocardial damage.
A retrospective analysis was performed on 833 STEMI patients who underwent primary percutaneous coronary intervention. The final residual thrombus burden was reclassified after the lesion was wired, and a thrombus aspiration or balloon dilatation was performed to restore and stabilise a thrombolysis in myocardial infarction (TIMI) 2-3 flow. Deferred stenting (DEI) was compared with immediate stenting (ISI) group, and the primary outcome was the incidence of no-/slow-reflow (TIMI ≤ 2, or TIMI 3 with myocardial blush grade < 2).
Overall, 47 patients (6.8%) had a residual large thrombus burden reclassified. The right coronary artery was the culprit vessel in 34 cases. More patients had coronary ectasia in the DSI group (P=.005). Fewer patients in the DSI had no-/slow-reflow (36% vs. 58%), and the myocardial blush grade 3 was more frequent in the DSI group (P=.005). After repeat coronary angiography in the DSI group, stenting was not performed in 56%, and oral anticoagulation was more frequent in the follow-up (P=.031). Major cardiac adverse events were similar between groups. There was a tendency to better left ventricular function in the DSI group (P=.056).
Deferred stenting may be an efficient option in STEMI patients with a residual large thrombus burden reclassified after achieving a stable TIMI 2-3 flow.
大血栓负荷的重新分类是ST段抬高型心肌梗死(STEMI)患者发生主要不良心脏事件和无复流的独立预测因素。残余血栓负荷较大的患者微血管功能障碍更严重,心肌损伤更大。
对833例行直接经皮冠状动脉介入治疗的STEMI患者进行回顾性分析。病变导丝通过后重新分类最终残余血栓负荷,并进行血栓抽吸或球囊扩张以恢复和稳定心肌梗死溶栓(TIMI)2-3级血流。将延迟支架置入(DEI)组与即刻支架置入(ISI)组进行比较,主要结局为无复流/慢复流(TIMI≤2,或TIMI 3且心肌灌注分级<2)的发生率。
总体而言,47例患者(6.8%)的残余大血栓负荷被重新分类。34例患者的罪犯血管为右冠状动脉。DSI组冠状动脉扩张的患者更多(P=0.005)。DSI组无复流/慢复流的患者较少(36%对58%),DSI组心肌灌注分级3级更为常见(P=0.005)。DSI组再次冠状动脉造影后,56%未进行支架置入,随访期间口服抗凝药物更为频繁(P=0.031)。两组主要心脏不良事件相似。DSI组左心室功能有改善趋势(P=0.056)。
对于在达到稳定的TIMI 2-3级血流后残余大血栓负荷重新分类的STEMI患者,延迟支架置入可能是一种有效的选择。